Osteoporosis treatment was associated with reduced hospitalization and mortality risks following fragility fracture after 80 years of age.

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.

PCOS was associated with an increased risk for vascular events including stroke among women with thrombotic disease, and a lower mean age.

ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care. As the sun rises over San Francisco, ...

There is increased risk for atrial fibrillation in patients with implanted devices exposed to hot outdoor temperatures.

MASLD rates have decreased, whereas liver fibrosis and cirrhosis rates have increased among US patients with type 2 diabetes since 2017.

Diabetes remission was more likely and laparoscopic surgery was less likely among women than men with paragangliomas and pheochromocytomas.

Compared with those with overweight and normal weight, people with obesity were more likely to report financial hardship and food insecurity.

Traditional cardiovascular risk assessment tools underperform among individuals with metabolic dysfunction-associated steatotic liver disease.

Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or ...

Higher UPF-consumption was linked to worse knee OA outcomes among women, including higher pain scores, worse physical function, and thinner knee cartilage.

The FDA has accepted the New Drug Application for ET-600, an oral solution formulation of desmopressin, for the treatment of central diabetes insipidus.